SlideShare una empresa de Scribd logo
1 de 21
MYOCARDIAL INFARCTION
Hussein A. Abid
Iraqi Medical Laboratory Association
Scientific Affairs & Cultural Relations
Training and development center
Lecture: 2
Date: 06/08/2018
MYOCARDIUM (cardiac muscle)
• Is one of the three major types of muscle, the others being
skeletal muscle and smooth muscle.
• It is an involuntary, striated muscle that constitutes the main
tissue of the walls of the heart.
• The myocardium forms a thick middle layer between the outer
layer of the heart wall (the epicardium) and the inner layer (the
endocardium).
• It is composed of individual heart muscle cells (cardiomyocytes)
joined together by intercalated discs, encased by collagen fibers
and other substances forming the extracellular matrix.
MYOCARDIUM
MYOCARDIUM (cardiac muscle)
• Cardiac muscle does the work of pumping blood to circulate it
throughout the rest of the body, work that is sometimes difficult
and always unceasing.
• To do its steady work, cardiac muscle requires ample blood
supply, which is delivered by the coronary circulation.
• Diseases of heart muscle are of major importance. These include
conditions caused by a restricted blood supply to the muscle
including angina pectoris and myocardial infarction, and other
heart muscle disease known as cardiomyopathies.
CARDIAC (HEART) PATHOLOGY
ISCHEMIC HEART DISEASE
• Hypoxemia (diminished transport of oxygen by the blood) less
deleterious than ischemia
• Also called coronary artery disease (CAD) or coronary heart
disease (CHD)
• The cause in 90% of cases, coronary atherosclerotic arterial
obstruction.
CARDIAC (HEART) PATHOLOGY
ISCHEMIC HEART DISEASE (mainly four types)
1. Myocardial infarction (MI)
2. Sudden cardiac death,
3. Angina pectoris; and
4. Chronic IHD with heart failure.
MYOCARDIAL INFARCTION
• Myocardial infarction (MI), or acute myocardial infarction (AMI).
• Commonly known as a heart attack, occurs when blood flow
decreases or stops to a part of the heart, causing damage to the
heart muscle.
• The most common symptom is chest pain or discomfort which
may travel into the shoulder, arm, back, neck, or jaw. Often it
occurs in the center or left side of the chest and lasts for more
than a few minutes. The discomfort may occasionally feel like
heartburn.
• Other symptoms may include shortness of breath, nausea,
feeling faint, a cold sweat, or feeling tired.
Diagram showing the blood
supply to the heart by the two
major blood vessels, the left and
right coronary arteries (labelled
LCA and RCA). A myocardial
infarction (2) has occurred with
blockage of a branch of the left
coronary artery (1).
MYOCARDIAL INFARCTION
• About 30% of people have atypical symptoms.
• Women more often have atypical symptoms than men.
• Among those over 75 years old, about 5% have had an MI
with little or no history of symptoms.
• An MI may cause heart failure, an irregular heartbeat,
cardiogenic shock, or cardiac arrest.
A myocardial infarction (MI)
occurs when an atherosclerotic
plaque slowly builds up in the
inner lining of a coronary artery
and then suddenly ruptures,
causing catastrophic thrombus
formation, totally occluding the
artery and preventing blood
flow downstream.
MYOCARDIAL INFARCTION
• Most myocardial infarctions occur due to coronary artery disease
• Risk factors include high blood pressure, smoking, diabetes,
lack of exercise, obesity, high blood cholesterol, poor diet,
and excessive alcohol intake, among others.
• The complete blockage of a coronary artery caused by a rupture
of an atherosclerotic plaque is usually the underlying mechanism
of an MI.
• Is are less commonly caused by coronary artery spasms, which
may be due to cocaine, significant emotional stress, and extreme
cold, among others.
MYOCARDIAL INFARCTION
• A number of tests are useful to help with diagnosis, including:
1. Electrocardiograms (ECGs)
2. Blood tests, and
3. Coronary angiography
• An ECG, which is a recording of the heart's electrical activity, may
confirm an ST elevation MI (STEMI) if ST elevation is present.
• Commonly used blood tests include troponin and less often creatine
kinase MB.
MYOCARDIAL INJURY
• Irreversible injury typically requires 30 minutes of ischemia.
• Chronic O2 deficiency makes cells more resistant.
• Time to diagnose and therapy is critical.
After 30 – 60
minutes, cell death
starts
80% of cells at risk
die within 3 hours
Almost 100% by 6
hours of ischemia
ACUTE CORONARY SYNDROME
CLINICAL DIAGNOSIS OF MI
• Silent MI: in diabetes mellitus, elderly, cardiac transplantation
recipients.
• Typical features: rapid, weak pulse and sweating profusely
(diaphoretic), dyspnea, chest pain.
LABORATORY DIAGNOSIS
 Diagnostic:
 Best markers: Troponins (T & I), both sensitive and cardio-specific
 Next best: CK-MB
 Predictive
 CRP > 3 mg/ L (highest risk)
MI diagnosis – WHO criteria
 History of ischemic type of chest discomfort
• Evolutionary ECG changes
• Rise and fall in serum cardiac markers
 Limitations:
• 1/3 of patients with AMI don’t present with chest pain
• Only 1/2 present with Q waves or ST elevation
• 1/2 of patients with suggestive chest pain have non-diagnostic ECG
• With use of new markers, additional 1/3 are diagnosed to have MI
• Perioperative MI and post PCI MI – symptoms may be absent and
ECG changes may be non-specific
MYOCARDIAL INFARCTION
• Treatment of an MI is time-critical.
• Aspirin is an appropriate immediate treatment for a suspected MI.
• Nitroglycerin or opioids may be used to help with chest pain;
however, they do not improve overall outcomes.
• Supplemental oxygen is recommended in those with low oxygen
levels or shortness of breath.
• In a STEMI, treatments attempt to restore blood flow to the heart,
and include percutaneous coronary intervention (PCI), where the
arteries are pushed open and may be stented, or thrombolysis,
where the blockage is removed using medications.
MYOCARDIAL INFARCTION
• People who have a non-ST elevation myocardial infarction
(NSTEMI) are often managed with the blood thinner heparin,
with the additional use of PCI in those at high risk.
• In people with blockages of multiple coronary arteries and
diabetes, coronary artery bypass surgery (CABG) may be
recommended rather than angioplasty. After an MI, lifestyle
modifications, along with long term treatment with aspirin, beta
blockers, and statins, are typically recommended.
• Worldwide, about 15.9 million myocardial infarctions
occurred in 2015.
MYOCARDIAL INFARCTION
• More than 3 million people had an ST elevation MI and more
than 4 million had an NSTEMI. STEMIs occur about twice as
often in men as women.
• About one million people have an MI each year in the United
States. In the developed world the risk of death in those who
have had an STEMI is about 10%.
• Rates of MI for a given age have decreased globally between
1990 and 2010.
• In 2011, AMI was one of the top five most expensive conditions
during inpatient hospitalizations in the US, with a cost of about
$11.5 billion for 612,000 hospital stays.

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
Ischemic Heart Disease
Ischemic Heart DiseaseIschemic Heart Disease
Ischemic Heart Disease
 
Pericarditis
PericarditisPericarditis
Pericarditis
 
Pericardial effusion
Pericardial effusionPericardial effusion
Pericardial effusion
 
coronary artery disease
coronary artery diseasecoronary artery disease
coronary artery disease
 
Heart failure
Heart failure Heart failure
Heart failure
 
Myocarditis
MyocarditisMyocarditis
Myocarditis
 
Pericarditis
PericarditisPericarditis
Pericarditis
 
coronary artery disease
coronary artery diseasecoronary artery disease
coronary artery disease
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
Acute coronary syndrome
Acute coronary syndrome Acute coronary syndrome
Acute coronary syndrome
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
Cardiac dyrrythmias
Cardiac dyrrythmiasCardiac dyrrythmias
Cardiac dyrrythmias
 
Acute Coronary Syndrome (NSTEMI)
Acute Coronary Syndrome (NSTEMI) Acute Coronary Syndrome (NSTEMI)
Acute Coronary Syndrome (NSTEMI)
 
Myocardial infraction or Heart attack
Myocardial infraction or Heart attackMyocardial infraction or Heart attack
Myocardial infraction or Heart attack
 
An Overview of Unstable angina
An Overview of Unstable anginaAn Overview of Unstable angina
An Overview of Unstable angina
 
Heart block
Heart blockHeart block
Heart block
 
Pericarditis
PericarditisPericarditis
Pericarditis
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Cardiac dysrhythmias
Cardiac dysrhythmiasCardiac dysrhythmias
Cardiac dysrhythmias
 

Similar a Myocardial infarction

Myocarditis & Cardiomyopathy.pptx
Myocarditis & Cardiomyopathy.pptxMyocarditis & Cardiomyopathy.pptx
Myocarditis & Cardiomyopathy.pptxAsokan R
 
Cerebrovascular accident
Cerebrovascular accidentCerebrovascular accident
Cerebrovascular accidentMa Icban
 
Coronary artery disease slide
Coronary artery disease slideCoronary artery disease slide
Coronary artery disease slide82657885
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarctionJen DC
 
Acute myocardial infarction
Acute myocardial infarctionAcute myocardial infarction
Acute myocardial infarctionhatch_jane
 
Nursing management patient with Myocardial infraction
Nursing management patient with Myocardial infraction Nursing management patient with Myocardial infraction
Nursing management patient with Myocardial infraction ANILKUMAR BR
 
Myocardial Infarction Nursing.pptx
Myocardial Infarction Nursing.pptxMyocardial Infarction Nursing.pptx
Myocardial Infarction Nursing.pptxAsraf Hussain
 
Ischemic Heart Disease lecture.pptx
Ischemic Heart Disease lecture.pptxIschemic Heart Disease lecture.pptx
Ischemic Heart Disease lecture.pptxRaufAnnaby2
 
ISCHEAMIC HEART.pptx
ISCHEAMIC HEART.pptxISCHEAMIC HEART.pptx
ISCHEAMIC HEART.pptx73AkshayRane
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarctionPriya
 
Afshan ali myocardial infarction
Afshan ali myocardial infarctionAfshan ali myocardial infarction
Afshan ali myocardial infarctionAamir Sharif
 
Afshan ali myocardial infarction
Afshan ali myocardial infarctionAfshan ali myocardial infarction
Afshan ali myocardial infarctionAamir Sharif
 
Coronary Angiography and PTCA
Coronary Angiography and PTCACoronary Angiography and PTCA
Coronary Angiography and PTCAAvneeshRaj1
 

Similar a Myocardial infarction (20)

MI.pptx
MI.pptxMI.pptx
MI.pptx
 
Myocarditis & Cardiomyopathy.pptx
Myocarditis & Cardiomyopathy.pptxMyocarditis & Cardiomyopathy.pptx
Myocarditis & Cardiomyopathy.pptx
 
Cerebrovascular accident
Cerebrovascular accidentCerebrovascular accident
Cerebrovascular accident
 
Ischemic heart disease (1)
Ischemic heart disease (1)Ischemic heart disease (1)
Ischemic heart disease (1)
 
Ischmic heart disease
Ischmic heart diseaseIschmic heart disease
Ischmic heart disease
 
Acute myocardial Infarction
Acute myocardial InfarctionAcute myocardial Infarction
Acute myocardial Infarction
 
Coronary artery disease slide
Coronary artery disease slideCoronary artery disease slide
Coronary artery disease slide
 
Angina ant its pharmacotherapy
Angina ant its pharmacotherapyAngina ant its pharmacotherapy
Angina ant its pharmacotherapy
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Acute myocardial infarction
Acute myocardial infarctionAcute myocardial infarction
Acute myocardial infarction
 
Nursing management patient with Myocardial infraction
Nursing management patient with Myocardial infraction Nursing management patient with Myocardial infraction
Nursing management patient with Myocardial infraction
 
Myocardial Infarction Nursing.pptx
Myocardial Infarction Nursing.pptxMyocardial Infarction Nursing.pptx
Myocardial Infarction Nursing.pptx
 
Ischemic Heart Disease lecture.pptx
Ischemic Heart Disease lecture.pptxIschemic Heart Disease lecture.pptx
Ischemic Heart Disease lecture.pptx
 
ISCHEAMIC HEART.pptx
ISCHEAMIC HEART.pptxISCHEAMIC HEART.pptx
ISCHEAMIC HEART.pptx
 
Ischaemic heart disease
Ischaemic heart diseaseIschaemic heart disease
Ischaemic heart disease
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Myocardialinfarction
Myocardialinfarction Myocardialinfarction
Myocardialinfarction
 
Afshan ali myocardial infarction
Afshan ali myocardial infarctionAfshan ali myocardial infarction
Afshan ali myocardial infarction
 
Afshan ali myocardial infarction
Afshan ali myocardial infarctionAfshan ali myocardial infarction
Afshan ali myocardial infarction
 
Coronary Angiography and PTCA
Coronary Angiography and PTCACoronary Angiography and PTCA
Coronary Angiography and PTCA
 

Más de Hussein Al-tameemi

Preventive role of probiotics to face SARS-CoV-2 pandemic
Preventive role of probiotics to face SARS-CoV-2 pandemicPreventive role of probiotics to face SARS-CoV-2 pandemic
Preventive role of probiotics to face SARS-CoV-2 pandemicHussein Al-tameemi
 
Erythrocyte Sedimentation Rate (ESR)
Erythrocyte Sedimentation Rate (ESR)Erythrocyte Sedimentation Rate (ESR)
Erythrocyte Sedimentation Rate (ESR)Hussein Al-tameemi
 
Blood collection, handling, and anticoagulants
Blood collection, handling, and anticoagulantsBlood collection, handling, and anticoagulants
Blood collection, handling, and anticoagulantsHussein Al-tameemi
 
الفحص المختبري وتفسير النتائج لالتهاب الكبد الفايروسي B
الفحص المختبري وتفسير النتائج لالتهاب الكبد الفايروسي Bالفحص المختبري وتفسير النتائج لالتهاب الكبد الفايروسي B
الفحص المختبري وتفسير النتائج لالتهاب الكبد الفايروسي BHussein Al-tameemi
 
Introduction to medical laboratory technology
Introduction to medical laboratory technologyIntroduction to medical laboratory technology
Introduction to medical laboratory technologyHussein Al-tameemi
 
Introduction to haematology laboratory
Introduction to haematology laboratoryIntroduction to haematology laboratory
Introduction to haematology laboratoryHussein Al-tameemi
 
CSF MICROBIOLOGICAL EXAMINATION – II
CSF MICROBIOLOGICAL EXAMINATION – IICSF MICROBIOLOGICAL EXAMINATION – II
CSF MICROBIOLOGICAL EXAMINATION – IIHussein Al-tameemi
 
CSF MICROBIOLOGICAL EXAMINATION – I
CSF MICROBIOLOGICAL EXAMINATION – ICSF MICROBIOLOGICAL EXAMINATION – I
CSF MICROBIOLOGICAL EXAMINATION – IHussein Al-tameemi
 
CSF processing in medical laboratory (01)
CSF processing in medical laboratory (01)CSF processing in medical laboratory (01)
CSF processing in medical laboratory (01)Hussein Al-tameemi
 
Medical Microbiology Laboratory (Introduction to Medical Virology)
Medical Microbiology Laboratory (Introduction to Medical Virology)Medical Microbiology Laboratory (Introduction to Medical Virology)
Medical Microbiology Laboratory (Introduction to Medical Virology)Hussein Al-tameemi
 

Más de Hussein Al-tameemi (20)

Preventive role of probiotics to face SARS-CoV-2 pandemic
Preventive role of probiotics to face SARS-CoV-2 pandemicPreventive role of probiotics to face SARS-CoV-2 pandemic
Preventive role of probiotics to face SARS-CoV-2 pandemic
 
General Urine Examination
General Urine ExaminationGeneral Urine Examination
General Urine Examination
 
Blood cell count
Blood cell countBlood cell count
Blood cell count
 
Erythrocyte Sedimentation Rate (ESR)
Erythrocyte Sedimentation Rate (ESR)Erythrocyte Sedimentation Rate (ESR)
Erythrocyte Sedimentation Rate (ESR)
 
Hematocrit determination
Hematocrit determinationHematocrit determination
Hematocrit determination
 
Hemoglobin estimation
Hemoglobin estimationHemoglobin estimation
Hemoglobin estimation
 
Blood collection, handling, and anticoagulants
Blood collection, handling, and anticoagulantsBlood collection, handling, and anticoagulants
Blood collection, handling, and anticoagulants
 
الفحص المختبري وتفسير النتائج لالتهاب الكبد الفايروسي B
الفحص المختبري وتفسير النتائج لالتهاب الكبد الفايروسي Bالفحص المختبري وتفسير النتائج لالتهاب الكبد الفايروسي B
الفحص المختبري وتفسير النتائج لالتهاب الكبد الفايروسي B
 
Introduction to medical laboratory technology
Introduction to medical laboratory technologyIntroduction to medical laboratory technology
Introduction to medical laboratory technology
 
Blood sample collection
Blood sample collectionBlood sample collection
Blood sample collection
 
Introduction to haematology laboratory
Introduction to haematology laboratoryIntroduction to haematology laboratory
Introduction to haematology laboratory
 
CSF BIOCHEMICAL EXAMINATION
CSF BIOCHEMICAL EXAMINATIONCSF BIOCHEMICAL EXAMINATION
CSF BIOCHEMICAL EXAMINATION
 
CSF MICROBIOLOGICAL EXAMINATION – II
CSF MICROBIOLOGICAL EXAMINATION – IICSF MICROBIOLOGICAL EXAMINATION – II
CSF MICROBIOLOGICAL EXAMINATION – II
 
CSF MICROBIOLOGICAL EXAMINATION – I
CSF MICROBIOLOGICAL EXAMINATION – ICSF MICROBIOLOGICAL EXAMINATION – I
CSF MICROBIOLOGICAL EXAMINATION – I
 
CSF processing in medical laboratory (01)
CSF processing in medical laboratory (01)CSF processing in medical laboratory (01)
CSF processing in medical laboratory (01)
 
Practical pathology
Practical pathologyPractical pathology
Practical pathology
 
Cardiac biomarkers - II
Cardiac biomarkers  - IICardiac biomarkers  - II
Cardiac biomarkers - II
 
Cardiac biomarkers - I
Cardiac biomarkers  - ICardiac biomarkers  - I
Cardiac biomarkers - I
 
Human heart
Human heartHuman heart
Human heart
 
Medical Microbiology Laboratory (Introduction to Medical Virology)
Medical Microbiology Laboratory (Introduction to Medical Virology)Medical Microbiology Laboratory (Introduction to Medical Virology)
Medical Microbiology Laboratory (Introduction to Medical Virology)
 

Último

Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 

Último (20)

Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 

Myocardial infarction

  • 1. MYOCARDIAL INFARCTION Hussein A. Abid Iraqi Medical Laboratory Association Scientific Affairs & Cultural Relations Training and development center Lecture: 2 Date: 06/08/2018
  • 2. MYOCARDIUM (cardiac muscle) • Is one of the three major types of muscle, the others being skeletal muscle and smooth muscle. • It is an involuntary, striated muscle that constitutes the main tissue of the walls of the heart. • The myocardium forms a thick middle layer between the outer layer of the heart wall (the epicardium) and the inner layer (the endocardium). • It is composed of individual heart muscle cells (cardiomyocytes) joined together by intercalated discs, encased by collagen fibers and other substances forming the extracellular matrix.
  • 4. MYOCARDIUM (cardiac muscle) • Cardiac muscle does the work of pumping blood to circulate it throughout the rest of the body, work that is sometimes difficult and always unceasing. • To do its steady work, cardiac muscle requires ample blood supply, which is delivered by the coronary circulation. • Diseases of heart muscle are of major importance. These include conditions caused by a restricted blood supply to the muscle including angina pectoris and myocardial infarction, and other heart muscle disease known as cardiomyopathies.
  • 5.
  • 6. CARDIAC (HEART) PATHOLOGY ISCHEMIC HEART DISEASE • Hypoxemia (diminished transport of oxygen by the blood) less deleterious than ischemia • Also called coronary artery disease (CAD) or coronary heart disease (CHD) • The cause in 90% of cases, coronary atherosclerotic arterial obstruction.
  • 7. CARDIAC (HEART) PATHOLOGY ISCHEMIC HEART DISEASE (mainly four types) 1. Myocardial infarction (MI) 2. Sudden cardiac death, 3. Angina pectoris; and 4. Chronic IHD with heart failure.
  • 8. MYOCARDIAL INFARCTION • Myocardial infarction (MI), or acute myocardial infarction (AMI). • Commonly known as a heart attack, occurs when blood flow decreases or stops to a part of the heart, causing damage to the heart muscle. • The most common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw. Often it occurs in the center or left side of the chest and lasts for more than a few minutes. The discomfort may occasionally feel like heartburn. • Other symptoms may include shortness of breath, nausea, feeling faint, a cold sweat, or feeling tired.
  • 9. Diagram showing the blood supply to the heart by the two major blood vessels, the left and right coronary arteries (labelled LCA and RCA). A myocardial infarction (2) has occurred with blockage of a branch of the left coronary artery (1).
  • 10. MYOCARDIAL INFARCTION • About 30% of people have atypical symptoms. • Women more often have atypical symptoms than men. • Among those over 75 years old, about 5% have had an MI with little or no history of symptoms. • An MI may cause heart failure, an irregular heartbeat, cardiogenic shock, or cardiac arrest.
  • 11. A myocardial infarction (MI) occurs when an atherosclerotic plaque slowly builds up in the inner lining of a coronary artery and then suddenly ruptures, causing catastrophic thrombus formation, totally occluding the artery and preventing blood flow downstream.
  • 12. MYOCARDIAL INFARCTION • Most myocardial infarctions occur due to coronary artery disease • Risk factors include high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol intake, among others. • The complete blockage of a coronary artery caused by a rupture of an atherosclerotic plaque is usually the underlying mechanism of an MI. • Is are less commonly caused by coronary artery spasms, which may be due to cocaine, significant emotional stress, and extreme cold, among others.
  • 13. MYOCARDIAL INFARCTION • A number of tests are useful to help with diagnosis, including: 1. Electrocardiograms (ECGs) 2. Blood tests, and 3. Coronary angiography • An ECG, which is a recording of the heart's electrical activity, may confirm an ST elevation MI (STEMI) if ST elevation is present. • Commonly used blood tests include troponin and less often creatine kinase MB.
  • 14. MYOCARDIAL INJURY • Irreversible injury typically requires 30 minutes of ischemia. • Chronic O2 deficiency makes cells more resistant. • Time to diagnose and therapy is critical. After 30 – 60 minutes, cell death starts 80% of cells at risk die within 3 hours Almost 100% by 6 hours of ischemia
  • 16. CLINICAL DIAGNOSIS OF MI • Silent MI: in diabetes mellitus, elderly, cardiac transplantation recipients. • Typical features: rapid, weak pulse and sweating profusely (diaphoretic), dyspnea, chest pain.
  • 17. LABORATORY DIAGNOSIS  Diagnostic:  Best markers: Troponins (T & I), both sensitive and cardio-specific  Next best: CK-MB  Predictive  CRP > 3 mg/ L (highest risk)
  • 18. MI diagnosis – WHO criteria  History of ischemic type of chest discomfort • Evolutionary ECG changes • Rise and fall in serum cardiac markers  Limitations: • 1/3 of patients with AMI don’t present with chest pain • Only 1/2 present with Q waves or ST elevation • 1/2 of patients with suggestive chest pain have non-diagnostic ECG • With use of new markers, additional 1/3 are diagnosed to have MI • Perioperative MI and post PCI MI – symptoms may be absent and ECG changes may be non-specific
  • 19. MYOCARDIAL INFARCTION • Treatment of an MI is time-critical. • Aspirin is an appropriate immediate treatment for a suspected MI. • Nitroglycerin or opioids may be used to help with chest pain; however, they do not improve overall outcomes. • Supplemental oxygen is recommended in those with low oxygen levels or shortness of breath. • In a STEMI, treatments attempt to restore blood flow to the heart, and include percutaneous coronary intervention (PCI), where the arteries are pushed open and may be stented, or thrombolysis, where the blockage is removed using medications.
  • 20. MYOCARDIAL INFARCTION • People who have a non-ST elevation myocardial infarction (NSTEMI) are often managed with the blood thinner heparin, with the additional use of PCI in those at high risk. • In people with blockages of multiple coronary arteries and diabetes, coronary artery bypass surgery (CABG) may be recommended rather than angioplasty. After an MI, lifestyle modifications, along with long term treatment with aspirin, beta blockers, and statins, are typically recommended. • Worldwide, about 15.9 million myocardial infarctions occurred in 2015.
  • 21. MYOCARDIAL INFARCTION • More than 3 million people had an ST elevation MI and more than 4 million had an NSTEMI. STEMIs occur about twice as often in men as women. • About one million people have an MI each year in the United States. In the developed world the risk of death in those who have had an STEMI is about 10%. • Rates of MI for a given age have decreased globally between 1990 and 2010. • In 2011, AMI was one of the top five most expensive conditions during inpatient hospitalizations in the US, with a cost of about $11.5 billion for 612,000 hospital stays.